The pro forma financials and accompanying explanatory notes were provided as Exhibit 99.1 to the 8-K filing. The company stated that these financials give effect to both the plan of reorganization and ...

On October 17, 2025, RedHill Biopharma completed a strategic transaction with Cumberland Pharmaceuticals involving Talicia®, its proprietary drug, by selling a 30% equity stake in newly formed Talicia ...

Novonesis provides outlook for 2024 with expected 5-7% organic sales growth and ~35% adj. EBITDA margin. Pro forma financials disclosed. Ester Baiget, CEO of Novonesis, said: “Today we provide key pro ...

The unaudited pro forma consolidated financial statements are based on available information and assumptions that the Company's management believes are reasonable as of the date of this filing. The ...

The Company is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is its abuse deterrent fentanyl transdermal system which ...

Redwire Corporation (NYSE:RDW) filed an updated Form 8-K on Monday to provide additional unaudited pro forma financial information related to its acquisition of Edge Autonomy Intermediate Holdings, ...

The MarketWatch News Department was not involved in the creation of this content. SINGAPORE, Aug. 29, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (NASDAQ: GCL) ("GCL" or the "Company"), a leading ...

The Omnicom group has formally filed unaudited pro forma financial statements with the U.S. Securities and Exchange Commission (SEC) on Wednesday, offering the first detailed, regulatory-compliant ...

Pro Forma Financials: The financial information included in the Form 6-K reflects certain pro forma adjustments to the historical consolidated Eros financial statements to (1) convert them from IFRS ...

Wolfspeed, Inc. (NYSE:WOLF) disclosed unaudited pro forma consolidated financial information on Thursday, reflecting the company’s recent prepackaged plan of reorganization and its adoption of fresh ...